New horizon of the combined BCG vaccine with probiotic and liraglutide in augmenting beta cell survival via suppression of TXNIP/NLRP3 pyroptosis signaling in Streptozocin–Induced diabetes mellitestype-1 in rats

Amira Karam Khalifa; Dina Sayed Abdelrahim; Dina Mohamed Mekawy; Reham Mohammad Raafat Hamed; Wafaa Rabee Mohamed; Nagwa Mahmoud Ramadan; Wael Mostafa; Rawan Ellackany; Emad Ali Albadawi; Walla'a A. Osman

Heliyon (Oct 2024)

New horizon of the combined BCG vaccine with probiotic and liraglutide in augmenting beta cell survival via suppression of TXNIP/NLRP3 pyroptosis signaling in Streptozocin–Induced diabetes mellitestype-1 in rats

Amira Karam Khalifa,
Dina Sayed Abdelrahim,
Dina Mohamed Mekawy,
Reham Mohammad Raafat Hamed,
Wafaa Rabee Mohamed,
Nagwa Mahmoud Ramadan,
Wael Mostafa,
Rawan Ellackany,
Emad Ali Albadawi,
Walla'a A. Osman

Affiliations

Amira Karam Khalifa: Department of Medical Pharmacology, Faculty of Medicine, Cairo University, El- Manial, Cairo 11562, Egypt; Department of Medical Pharmacology, Faculty of Medicine, Nahda University, 62521, Beni Suef, Egypt; Corresponding author. Faculty of Medicine, Cairo University, El Manial, Cairo, 11562, Egypt.
Dina Sayed Abdelrahim: Department of Clinical Pharmacology, Faculty of Medicine, Ain Shams University, Egypt; Department of Pharmacology, Faculty of Medicine, Modern University for Technology and Information, Cairo, Egypt
Dina Mohamed Mekawy: Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Badr University in Cairo, Badr City, Egypt; Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Cairo University, Cairo, Egypt
Reham Mohammad Raafat Hamed: Department of Medical Microbiology and Immunology Department, Faculty of Medicine, Cairo University, Egypt
Wafaa Rabee Mohamed: Department of Histology and Cell Biology, Faculty of Medicine, Ain Shams University, Egypt; Department of Histology and Cell Biology, Faculty of Medicine, Modern University for Technology and Information, Egypt
Nagwa Mahmoud Ramadan: Department of Physiology, Faculty of Medicine, Cairo University, El Manial, Cairo 11562, Egypt
Wael Mostafa: Faculty of Medicine, Modern University for Technology and Information, Cairo, Egypt
Rawan Ellackany: Faculty of Medicine, Modern University for Technology and Information, Cairo, Egypt
Emad Ali Albadawi: Department of Basic Medical Science, College of Medicine, Taibah University, KSA, Saudi Arabia
Walla'a A. Osman: Department of Medical Pharmacology, Faculty of Medicine, Cairo University, El- Manial, Cairo 11562, Egypt

Journal volume & issue: Vol. 10, no. 20
p. e38932

Abstract

Read online

Background: An ideal anti-diabetic type-1 pharmacotherapy should combine abrogation of beta cell pyroptosis with enhancement of beta cell mass. Objectives: The study investigated the potential synergism from combining the Bacillus Calmette-Guerin (BCG) vaccine with liraglutide (LIR) and probiotics in mitigating Streptozocin (STZ)-induced Type1diabetes mellitus in albino rats via suppression of TXNIP/NLRP3 signaling. Methods: Induction of diabetes was performed by two I.V. injections of 50 mg/kg of STZ in male Wistar rats. Forty-eight rats were randomly allocated into six groups: Normal control group; STZ -diabetic group; BCG group; BCG + LIR group; BCG + probiotic group; BCG + LIR + probiotic group. The rats were sacrificed after 8 weeks of treatment. Results: The STZ-diabetic group exhibited significant elevation of fasting blood sugar and HbA1c with remarkably decreased serum insulin along with a considerable increase in pancreatic proinflammatory cytokines (TNF-α, NLRP3, IL-1β, and NFκB) and apoptotic markers (ASK-1, IAPP, TXNIP, and Caspase-3) with prominently compromised oxidative scavenging capacity in addition to structural alteration in the pancreatic histoarchitecture with decreased insulin immunostaining. Conversely, diabetic-treated groups, especially the BCG + LIR + probiotic group, were superior in amelioration of STZ-induced pyroptosis of pancreatic islets evidenced by a significant decline in inflammatory cytokines and apoptotic markers with a remarkable upgrade in redox balance, Furthermore, the mitigation in the altered histopathological picture of the pancreas with enhanced insulin immunostaining has been was mirrored on the significant improvement of glucose homeostasis parameters. Conclusions: Noteworthy, BCG combination with liraglutide and probiotic might be a promising repurposed therapeutic modality in the management of type-1 diabetes mellites via targeting pancreatic TXNIP/NLRP3 signaling pathway.

Published in Heliyon

ISSN: 2405-8440 (Online)
Publisher: Elsevier
Country of publisher: United Kingdom
LCC subjects: Science: Science (General); Social Sciences: Social sciences (General)
Website: https://www.cell.com/heliyon/home

About the journal

Abstract

Keywords